Skip to main content
. 2025 Mar 24;14(4):803–818. doi: 10.1007/s40121-025-01127-0

Table 2.

Resistance pattern of isoniazid, fluoroquinolone, aminoglycoside, and ethionamide among patients with pulmonary tuberculosis as determined by the gold standard Lowenstein–Jensen proportion method

Resistance pattern Total cases (n = 793)
n (%)
New cases (n = 611)
n (%)
Re-treated cases (n = 182)
n (%)
P value
All sensitive 368 (46.4) 423 (69.2) 59 (32.4)  < 0.001
All resistant 4 (0.5) 0 (0) 4 (2.2)  < 0.001
Any resistance
 INH 284 (35.8) 164 (26.8) 120 (65.9)  < 0.001
 FLQ 114 (14.4) 67 (11.0) 47 (25.8)  < 0.001
 AMG 7 (0.9) 0 (0) 7 (3.8)  < 0.001
 ETH 192 (24.2) 149 (24.4) 43 (23.6) 0.825
Mono-drug resistant
 INH 140 (17.7) 88 (14.4) 52 (28.6)  < 0.001
 FLQ 35 (4.4) 29 (4.7) 6 (3.3) 0.418
 ETH 100 (12.6) 94 (15.4) 6 (3.3)  < 0.001
 AMG 0 (0) 0 (0) 0 (0)
Poly-drug resistant
 INH + FLQ 55 (6.9) 26 (4.3) 29 (15.9)  < 0.001
 INH + FLQ + AMG 2 (0.3) 0 (0) 2 (1.1) 0.009
 INH + FLQ + ETH 12 (1.5) 7 (1.1) 5 (2.7) 0.115
 INH + ETH 70 (8.8) 43 (7.0) 27 (14.8)  < 0.001
 FLQ + ETH 6 (0.8) 5 (0.8) 1 (0.5) 0.676
 INH + AMG 1 (0.1) 0 (0) 1 (0.5) 0.080

INH isoniazid, FLQ fluoroquinolones, AMG aminoglycoside, ETH ethionamide